GeneDx Hldgs Analyst Ratings
Goldman Sachs Maintains Neutral on GeneDx Hldgs, Raises Price Target to $54
Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating
Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating
Craig-Hallum Issues a Buy Rating on GeneDx Holdings (WGS)
GeneDx Holdings Price Target Raised to $45.00/Share From $35.00 by BTIG
GeneDx Hldgs Analyst Ratings
Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating, Raises Target Price to $46
BTIG Maintains GeneDx Holdings(WGS.US) With Buy Rating, Raises Target Price to $45
Buy Rating Affirmed: GeneDx Holdings' Financial Growth and Promising Outlook Propel Stock's Upward Trajectory
TD Cowen Maintains GeneDx Holdings(WGS.US) With Buy Rating, Raises Target Price to $50
GeneDx Hldgs Analyst Ratings
GeneDx Hldgs Analyst Ratings
GeneDx Hldgs Analyst Ratings
TD Cowen Adjusts GeneDx Holdings' Price Target to $24 From $14, Keeps Buy Rating
GeneDx Hldgs Analyst Ratings
BTIG Maintains Buy on GeneDx Hldgs, Raises Price Target to $19
GeneDx Holdings (WGS) Receives a Buy From BTIG
GeneDx Hldgs Analyst Ratings
GeneDx Hldgs Analyst Ratings